产品编号 :
Cas No. :
CAS No. |
58812-37-6 |
|---|---|
中文名称 |
(1S,2aR,3aS,3bS,4R,5aR,6R,7R,9S,9aS,9bR,11R,11aR,14R)-1-(呋喃-3-基)-4,9,14-三羟基-3b,6,11a-三甲基-10-氧代-十四氢-1H-6,9a-(亚甲二氧亚甲基)萘并[1',2':6,7]茚并[1,7a-b]环氧烯-7,11-二基二乙酸酯 |
英文名称 |
(1S,2aR,3aS,3bS,4R,5aR,6R,7R,9S,9aS,9bR,11R,11aR,14R)-1-(Furan-3-yl)-4,9,14-trihydroxy-3b,6,11a-trimethyl-10-oxotetradecahydro-1H-6,9a-(methanooxymethano)naphtho[1',2':6,7]indeno[1,7a-b]oxirene-7,11-diyl diacetate |
别名 |
12-Acetoxyamoorastatin | AKOS025311566 | MFCD00210564 | CHEBI:192461 | Toosendanin | [(1S,2R,4R,5R,6S,8R,10S,11S,12R,14R,15R,16R,19S,21R)-4-acetyloxy-6-(uran-3-yl)-12,16,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.01,14.02,11.05,10.08 |
标准英文名 |
(1S,2aR,3aS,3bS,4R,5aR,6R,7R,9S,9aS,9bR,11R,11aR,14R)-1-(furan-3-yl)-4,9,14-trihydroxy-3b,6,11a-trimethyl-10-oxotetradecahydro-1H-6,9a-(methanooxymethano)naphtho[1',2':6,7]indeno[1,7a-b]oxirene-7,11-diyl diacetate |
MDL No. |
MFCD00210564 |
分子式 |
C30H38O11 |
分子量 |
574.62 |
精确分子量 |
574.24 |
SMILES |
C[C@@]1([C@@]2([H])[C@@]3([C@@H](O)C[C@@H](OC(C)=O)[C@]4(C)[C@H](O)OC3)[C@@]4([H])C[C@H]1O)[C@]56[C@]([C@@H](OC(C)=O)C2=O)(C)[C@H](C7=COC=C7)C[C@@]5([H])O6 |
标准SMILES |
C[C@]12[C@@H]3C[C@@H](O)[C@]4(C)[C@H](C(=O)[C@H](OC(C)=O)[C@@]5(C)[C@@H](C[C@H]6O[C@]546)C4=COC=C4)[C@@]3(CO[C@H]1O)[C@@H](O)C[C@H]2OC(C)=O |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
NAHTXVIXCMUDLF-RFNFAWMESA-N |
危险类别(旧) |
H301 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 3) |
|---|---|
UN No. |
2811,2811,2811 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|